53.20 USD
↗ 2.34 (4.60%)AT CLOSE (11:59 AM EDT)
Enliven Therapeutics, Inc. Common Stock
ELVNNASDAQ • USD
53.65
↗ 0.45 (0.84%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
53.65
↗ 0.45 (0.84%)
Market: CLOSED
ELVN is currently priced at $53.16. The technical outlook is "Strong Buy" and the fundamental picture shows "Neutral". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. On the valuation front, ELVN trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Jul 17, 2026.
Open?$49.72
High?$54.10
Low?$49.56
Prev. Close?$50.86
Volume?818.0K
Avg. Volume?2.0M
VWAP?$52.61
Rel. Volume?0.42x
Bid / Ask
Bid?$45.39 × 100
Ask?$61.04 × 100
Spread?$15.65
Midpoint?$53.22
Valuation & Ratios
Market Cap?3.6B
Shares Out?60.9M
Float?45.4M
Float %?76.5%
P/E Ratio?N/A
P/B Ratio?8.01
EPS?-$1.38
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
Employees
61
Market Cap
3.6B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2023-02-24
Address
6200 LOOKOUT ROAD
BOULDER, CO 80301
Phone: 720-647-8519
BOULDER, CO 80301
Phone: 720-647-8519
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?65
Short Sent.?21
Piotroski F-Score?0/9Weak
Altman Z-Score?189.01Safe
Confidence?49%Low
Short InterestHigh
Short % of Float?18.79%High
Short Interest?8.5M
Days to Cover?3.1
Free Float45.4M
Avg Daily Volume2.8M
Settlement Date2026-06-30
Financial Health
Current Ratio?40.32Strong
Quick Ratio?40.32Strong
Cash Ratio?11.51Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?8.01HIGH▾
Peers100
S&P23
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-30.3CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-21.8%WEAK▾
S&P7
ROA?-21.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-65603000
Enterprise Value?$3.5B
Fundamentals ratios updated end of day